Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Leukemia
|
September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
A Tanase, N Schmitz, H Stein, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 5, 2015
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis
R Crocchiolo, S Bramanti, A Vai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide
M Balzarotti, M Spina, B Sarina, et al.
Bone Marrow Transplantation
|
April 29, 2018
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
A Mussetti, C De Philippis, C Carniti, et al.
Bone Marrow Transplantation
|
February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT
L Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation
|
December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT
L Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation
|
August 7, 2012
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry
M Martino, A Ballestrero, A Zambelli, et al.
Bone Marrow Transplantation
|
July 8, 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors
L Castagna, R Crocchiolo, S Furst, et al.
Bone Marrow Transplantation
|
January 27, 2015
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant
L Castagna, R Crocchiolo, L Giordano, et al.
Bone Marrow Transplantation
|
November 25, 2014
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY
A Roberto, L Castagna, S Gandolfi, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Leukemia
|
September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
A Tanase, N Schmitz, H Stein, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 5, 2015
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis
R Crocchiolo, S Bramanti, A Vai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide
M Balzarotti, M Spina, B Sarina, et al.
Bone Marrow Transplantation
|
April 29, 2018
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
A Mussetti, C De Philippis, C Carniti, et al.
Bone Marrow Transplantation
|
February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT
L Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation
|
December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT
L Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation
|
August 7, 2012
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry
M Martino, A Ballestrero, A Zambelli, et al.
Bone Marrow Transplantation
|
July 8, 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors
L Castagna, R Crocchiolo, S Furst, et al.
Bone Marrow Transplantation
|
January 27, 2015
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant
L Castagna, R Crocchiolo, L Giordano, et al.
Bone Marrow Transplantation
|
November 25, 2014
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY
A Roberto, L Castagna, S Gandolfi, et al.
Page
of 10